SYRE - CIK 0001636282
Spyre Therapeutics, Inc. has filed 762 documents with the SEC between 2015 and 2026. The most frequent type is insider trade (195 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SEC correspondence | UPLOAD | 2023-10-20 | - |
| S-1/A | - | 2023-10-10 | - |
| PRER14A | - | 2023-10-10 | - |
| Major company event | 8-K | 2023-10-10 | 2023-06-22 |
| Company correspondence | CORRESP | 2023-10-06 | - |
| Company correspondence | CORRESP | 2023-10-06 | - |
| Major company event | 8-K | 2023-10-05 | 2023-09-29 |
| SEC correspondence | UPLOAD | 2023-09-29 | - |
| Major company event | 8-K | 2023-09-25 | 2023-09-19 |
| Company correspondence | CORRESP | 2023-09-08 | - |
| Major company event | 8-K | 2023-09-08 | 2023-09-07 |
| Major company event | 8-K | 2023-09-05 | 2023-08-31 |
| Insider trade | 4 | 2023-09-05 | 2023-09-01 |
| New insider ownership | 3 | 2023-09-05 | 2023-09-01 |
| Insider trade | 4 | 2023-09-05 | 2023-09-01 |
| New insider ownership | 3 | 2023-09-05 | 2023-09-01 |
| SEC correspondence | UPLOAD | 2023-08-28 | - |
| Major company event | 8-K | 2023-08-11 | 2023-08-07 |
| Quarterly report | 10-Q | 2023-08-11 | 2023-06-30 |
| Major company event | 8-K | 2023-08-11 | 2023-08-11 |
| PRE 14A | - | 2023-08-08 | 2023-08-07 |
| Securities registration | S-3 | 2023-08-07 | - |
| Passive ownership stake | SC 13G | 2023-07-28 | - |
| Major company event | 8-K | 2023-07-27 | 2023-07-27 |
| Passive ownership stake | SC 13G | 2023-07-18 | - |
| Major company event | 8-K | 2023-07-14 | 2023-07-13 |
| Passive ownership stake | SC 13G | 2023-07-10 | - |
| D | - | 2023-07-06 | - |
| Passive ownership stake | SC 13G | 2023-07-03 | - |
| Insider trade | 4 | 2023-06-30 | 2023-06-22 |
| Insider trade | 4 | 2023-06-30 | 2023-06-22 |
| Insider trade | 4 | 2023-06-30 | 2023-06-22 |
| Insider trade | 4 | 2023-06-30 | 2023-06-22 |
| Insider trade | 4 | 2023-06-30 | 2023-06-22 |
| Activist ownership stake | SC 13D | 2023-06-30 | - |
| Passive ownership stake | SC 13G | 2023-06-30 | - |
| New insider ownership | 3 | 2023-06-30 | 2023-06-22 |
| New insider ownership | 3 | 2023-06-30 | 2023-06-22 |
| New insider ownership | 3 | 2023-06-30 | 2023-06-22 |
| Passive ownership stake | SC 13G | 2023-06-30 | - |
| Major company event | 8-K | 2023-06-23 | 2023-06-21 |
| Major company event | 8-K | 2023-06-22 | 2023-06-22 |
| Major company event | 8-K | 2023-06-09 | 2023-06-06 |
| Proxy materials | DEFA14A | 2023-05-19 | - |
| Major company event | 8-K | 2023-05-19 | 2023-05-15 |
| Quarterly report | 10-Q | 2023-05-11 | 2023-03-31 |
| Major company event | 8-K | 2023-05-11 | 2023-05-11 |
| Major company event | 8-K | 2023-04-25 | 2023-04-25 |
| Annual report to shareholders | ARS | 2023-04-17 | 2022-12-31 |
| Proxy statement | DEF 14A | 2023-04-17 | 2023-06-06 |